Shiseido Company Limited has transited to a Company with Three Statutory Committees based on resolution of the Annual General Meeting of Shareholders held on March 26, 2024. The Board of Directors has focused on determining the basic management policy and management strategy while overseeing their execution, while also delegating significant authority to the Corporate Executive Officers, thereby accelerating decision-making in business execution and the implementation of business strategies.
Corporate governance Structure Chart
In addition, with the recognition that promoting of the Three Lines Model contributes to strengthening corporate governance, the business department on the first line, the HQ Corporate departments and the regional headquarters on the second line and the Internal Audit Department on the third line work together while aiming to promote healthy growth strategies and enhance sustainable corporate value, and establishment and improvement of risk scenarios and risk mitigation activities are continuously carried out.
The Board of Directors meetings are held approximately once a month. It focuses on deciding basic
management policy and management strategy and overseeing the implementation thereof to reinforce the oversight
function and promote prompt execution in a rapidly changing environment. In addition, the Board of Directors
discusses and decides matters stipulated in laws and regulations and the Company’s Articles of Incorporation as
well as matters provided for in the Regulations of the Board of Directors, and delegates the authority to decide
on other matters to Representative Corporate Executive Officers or Corporate Executive Officers.
The
Company’s Board of Directors is composed of twelve (12) Directors, including eight (8) Independent External
Directors.
We held the Board of Directors meetings thirteen (13) times in fiscal year 2025.
From the
executive side, reports and proposals were made primarily regarding management strategies including the “2030
Medium-Term Strategy” and the “Action Plan 2025–2026” and their progress, the status of structural reforms, risk
management and internal controls (including material risks, cybersecurity and quality management), as well as IR
activities and responses from the capital markets. In addition to these discussions, regular reports were
provided by the Nomination, Compensation and Audit Committees. Accordingly, the Board of Directors effectively
performed its oversight function.
In addition to the abovementioned thirteen (13) meetings of the Board of Directors, pursuant to the provisions of Article 370 of the Companies Act and Article 26, Paragraph 2 of the Company’s Articles of Incorporation, there was one deemed resolution where a resolution at a Board of Directors meeting is deemed to have been passed.
The Nominating Committee resolves matters such as proposals regarding appointment and dismissal of
directors to be submitted to general meetings of shareholders and matters regarding the succession of directors.
In addition, the Nominating Committee deliberate appointment and dismissal of the representative Corporate
Executive Officers and Corporate Executive Officers, areas for which Corporate Executive Officers take
responsibility, appointment and dismissal of the CEO, as well as matters regarding the succession of the CEO
etc. and reports results of the deliberations to the Board of Directors.
The Committee is composed of five
(5) Independent External Directors and its chairperson is selected from the committee members with the
resolution of the Nominating Committee.
We held the Nominating Committee meetings thirteen (13) times in
2025.
It mainly discussed the succession of Directors, made resolutions regarding the selection of Director
candidates to be submitted to the shareholders' meeting, and monitored the implementation status of the CEO
succession. Additionally, the selection of the Representative Corporate Executive Officers and Corporate
Executive Officers, and the determination of the areas
of responsibility for the Corporate Executive Officers, providing recommendations to the Board of Directors.
The Compensation Committee resolves policies on decisions regarding remuneration of Directors and
Corporate Executive Officers, designs of the remuneration policy for Directors and Corporate Executive Officers,
and details of remuneration to individual Directors and Corporate Executive Officers, etc.
The committee is
composed of five (5)Independent External Directors and its chairperson is selected from the committee members
with the resolution of the Compensation Committee.
We held the Compensation Committee thirteen (13) times
in 2025.
It mainly discussed and resolved matters regarding the performance indicators for annual bonuses
and long-term incentives, as well as the compensation of Directors and Corporate Executive Officers.
Additionally, it oversaw the determination of compensation for Executive Officers other than Directors and
Corporate Executive Officers.
The Audit Committee conducts audits and prepares audit reports on performance of duties of Directors and Corporate Executive Officers, etc., and makes decisions on proposals for appointment, dismissal, or non-reappointment of the accounting auditor submitted to General Meetings of Shareholders. The Committee is composed of five (5) members, comprising three (3) Independent External Directors and two (2) full-time Audit Committee members who are Directors not concurrently serving as Corporate Executive Officers, and its Chairperson is an Independent External Director selected from the Committee members by the resolution of the Audit Committee.
Click here for the activities of the Audit Committee in fiscal year 2025
[Global Strategy Committee]
Prior to decision-making by the CEO, this committee deliberates on group policies, organizational transformations, new businesses/brand launches and other particularly import matters for the Shiseido Group.
[Business Plan Meeting]
This meeting discusses business strategies and plans for core brands, regions, and key corporate functions.
[Global Risk Management & Compliance Committee]
The committee aims to accurately grasp global and regional social changes and the current situation of the Group. Based on this, it identifies management risk factors, deliberates prioritized material risks and countermeasures against the risks as well as the important matters regarding ethics and compliance.
Related Information:
ABOUT US
BRANDS
SUSTAINABILITY
INNOVATION
INVESTORS